- Review
Small Interfering Ribonucleic Acid as Lipid-Lowering Therapy: Inclisiran in Focus
- Jelena Rakocevic,
- Milan Dobric,
- Rada Vucic,
- Matija Furtula,
- Ivan Zaletel,
- Katarina Milutinovic,
- Ana Ilijevski,
- Milica Labudovic Borovic,
- Miloje Tomasevic and
- Milos Bajcetic
The PCSK9 (Proprotein Convertase Subtilisin/Kexin type 9) enzyme interferes with the metabolism of low-density lipoprotein (LDL) cholesterol. Inhibition of PCSK9 results in lower LDL cholesterol levels, which can be achieved by different molecular pa...

